Patents

Merz Patent Notices

Please see the following table for U.S. patents covering Merz products. The absence of a product name from this list or U.S. patent number as associated with any listed product does not constitute a waiver of Merz’s patent, trademark, or other intellectual property rights concerning that product.

Product Name	Patent Name
Xeomin^® (incobotulinumtoxinA)	US7,927,836 US9,937,245 US9,217,172 US10,653,754 US11,529,398 US10,709,772 US10,921,312
Radiesse^® (injectable implant)	US7,527,610 US7,303,551
Radiesse^® (+) Lidocaine injectable implant	US7,527,610 US7,303,551

Platform change – You are leaving this page.

You are leaving this website. With respect to the content of the following page, as well as to links to other websites located on this page, Merz Therapeutics U.S. has no way of controlling the content of these sites. Merz Therapeutics U.S. assumes no responsibility for the content of these sites or the consequences of their use by visitors. However, we ask you to notify us immediately of any illegal content on the linked sites.

Change of country – You are leaving this page.

You are leaving this website. The content of the following sites maintained by the parent company or another affiliated company, or links to other sites located on this site, is subject to the legal requirements of the country in which the site is maintained. Merz Therapeutics U.S. accepts no responsibility whatsoever for the content of these websites or for the consequences of their use by visitors. However, we ask you to notify us immediately of any illegal content on the linked sites.